Butler JV, Whittington JE, Holland AJ, Boer H, Clarke D, Webb T : Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study
First, diabetes blunts weight loss by roughly 6 to 7 percentage points versus non-diabetic obesity at the same dose, because long-standing high glucose dampens the metabolic cascade the drug works through. Second, the 10-to-15 mg step keeps adding weight loss in every band
The two compounds operate on different timelines
According to the Ozempic SmPC, use is not recommended in patients with severe gastrointestinal disease, including severe gastroparesis
There is a knowledge gap in screening and management strategies for osteoporosis in patients undergoing GLP-1Ra
It is an effective weight loss drug, functioning by mimicking a satiety hormone, reducing appetite, and slowing gastric emptying